DK1365737T3 - Stabile salte af o-acetylsalicylsyre med basiske aminosyrer - Google Patents

Stabile salte af o-acetylsalicylsyre med basiske aminosyrer

Info

Publication number: DK1365737T3
Authority: DK; Denmark
Prior art keywords: amino acids; basic amino; acetylsalicylic acid; stable salts; salts
Prior art date: 2000-07-18

Application number

DK01956511T

Other languages

Danish (da)

English (en)

Inventor

Gerhard Franckowiak

Hubert Appolt

Gregor Leifker

Hans-Peter Wirges

Wolfram Ledwoch

Original Assignee

Bayer Healthcare Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-18

Filing date

2001-07-05

Publication date

2005-07-11

2001-07-05 Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag

2005-07-11 Application granted granted Critical

2005-07-11 Publication of DK1365737T3 publication Critical patent/DK1365737T3/da

Links

BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical class CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title 1
150000001413 amino acids Chemical class 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)

DK01956511T 2000-07-18 2001-07-05 Stabile salte af o-acetylsalicylsyre med basiske aminosyrer DK1365737T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10034802A DE10034802A1 (de)	2000-07-18	2000-07-18	Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
PCT/EP2001/007669 WO2002005782A2 (fr)	2000-07-18	2001-07-05	Sels stables d'acide o-acetylsalicylique avec des acides amines basiques

Publications (1)

Publication Number	Publication Date
DK1365737T3 true DK1365737T3 (da)	2005-07-11

Family

ID=7649258

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01956511T DK1365737T3 (da)	2000-07-18	2001-07-05	Stabile salte af o-acetylsalicylsyre med basiske aminosyrer

Country Status (33)

Country	Link
US (2)	US6773724B2 (fr)
EP (1)	EP1365737B1 (fr)
JP (2)	JP2004507463A (fr)
KR (1)	KR100773658B1 (fr)
CN (1)	CN1205176C (fr)
AR (1)	AR030305A1 (fr)
AT (1)	ATE293589T1 (fr)
AU (2)	AU7847101A (fr)
BR (1)	BR0112538A (fr)
CA (1)	CA2416288C (fr)
CR (1)	CR6888A (fr)
CZ (1)	CZ300337B6 (fr)
DE (2)	DE10034802A1 (fr)
DK (1)	DK1365737T3 (fr)
EC (1)	ECSP034437A (fr)
ES (1)	ES2241849T3 (fr)
GT (1)	GT200100134A (fr)
HR (1)	HRP20030108B1 (fr)
HU (1)	HUP0302053A3 (fr)
IL (2)	IL153873A0 (fr)
MX (1)	MXPA03000510A (fr)
MY (1)	MY134521A (fr)
NO (1)	NO20030222D0 (fr)
PE (1)	PE20020267A1 (fr)
PL (1)	PL204593B1 (fr)
PT (1)	PT1365737E (fr)
RS (1)	RS50329B (fr)
SK (1)	SK286162B6 (fr)
SV (1)	SV2002000557A (fr)
TW (1)	TWI299729B (fr)
UY (1)	UY26841A1 (fr)
WO (1)	WO2002005782A2 (fr)
ZA (1)	ZA200300469B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6346510B1 (en)	1995-10-23	2002-02-12	The Children's Medical Center Corporation	Therapeutic antiangiogenic endostatin compositions
DE10202019A1 (de) *	2002-01-18	2003-07-24	Bayer Ag	Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
US8142810B2 (en)	2002-05-30	2012-03-27	The Procter & Gamble Company	Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
ES2330321T3 (es) *	2003-05-16	2009-12-09	Cephalon France	Procedimiento de sintesis de modafinilo.
CA2576971A1 (fr) *	2004-08-20	2006-03-02	Entremed, Inc.	Compositions et procedes comportant des antagonistes de recepteur active par la proteinase
US20060166901A1 (en) *	2005-01-03	2006-07-27	Yu Ruey J	Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
DE102005025283A1 (de) *	2005-06-02	2006-12-07	Bayer Healthcare Ag	Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
DE102005049293A1 (de) *	2005-10-15	2007-04-26	Bayer Healthcare Ag	Kombinationspräparate von Salzen oder o-Acetylsalicylsäure
AU2006346195B2 (en)	2006-07-09	2013-03-07	Techfields Biochem Co. Ltd	Positively charged water-soluble prodrugs of aspirin
US20090221703A1 (en)	2006-07-09	2009-09-03	Chongxi Yu	High penetration composition and uses thereof
US20090238763A1 (en) *	2006-07-09	2009-09-24	Chongxi Yu	High penetration compositions and uses thereof
JP2010529101A (ja) *	2007-06-04	2010-08-26	テックフィールズインコーポレイテッド	非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
DE102008004386A1 (de)	2008-01-14	2009-07-23	Activaero Gmbh	Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
CN101314029B (zh) *	2008-06-18	2010-12-08	四川省农业科学院实验场	乙酰水杨酸肽及其制备方法
US20100120727A1 (en) *	2008-11-12	2010-05-13	Kyphia Pharmaceuticals, Inc.	Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
CN108191846B (zh)	2008-12-04	2021-08-20	于崇曦	高穿透性组合物及其应用
EP2445861B1 (fr) *	2009-06-25	2014-03-26	Tetra, Sia	Nouveaux sels de l'acide acetylsalicylique
CN101633624B (zh) *	2009-08-04	2013-05-01	蚌埠丰原医药科技发展有限公司	改进的赖氨匹林的制备方法
FR2950625B1 (fr) *	2009-09-30	2016-12-02	Holis Tech	Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
FR2965261B1 (fr)	2009-09-30	2012-10-26	Holis Technologies	Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
FR2973370B1 (fr) *	2011-03-29	2013-05-03	Holis Technologies	Procede a faible cout pour la preparation d'un acide o-acetylsalicyclique et d'un acide amine basique
CN102503845A (zh) *	2011-09-28	2012-06-20	广州普星药业有限公司	一种dl-赖氨酸阿司匹林盐的制备方法及其应用
HK1207562A1 (en)	2012-01-18	2016-02-05	苏州泰飞尔医药有限公司	High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
CN102976962B (zh) *	2012-11-20	2015-02-04	南京工业大学	L-鸟氨酸阿司匹林复盐及其制备方法和应用
FR3021654B1 (fr)	2014-05-28	2016-06-24	Unither Pharmaceuticals	Procede de preparation d'un sel d'acide acetylsalicylique et d'un acide amine basique
CA3044137C (fr) *	2016-12-23	2021-06-15	Ventaleon Gmbh	Synthese amelioree de particules d'acetylsalicylate de lysine · glycine
EP3630120A4 (fr)	2017-05-30	2021-01-13	Rhoshan Pharmaceuticals, Inc.	Dépôt en flacon d'acide o-acétylsalicylique (aspirine) stable, stérile et cristallin
KR20200035047A (ko) *	2017-08-03	2020-04-01	산텐 세이야꾸 가부시키가이샤	클로르헥시딘을 함유하는 의약 조성물
CN113105326A (zh) *	2021-03-24	2021-07-13	海南卓华制药有限公司	赖氨匹林的制备方法及应用
CN114478287A (zh) *	2021-12-31	2022-05-13	蚌埠丰原医药科技发展有限公司	一种赖氨匹林晶型及制备方法和应用
AU2023205426A1 (en)	2022-01-05	2024-06-13	Aspiair Gmbh	Improved synthesis of lysine acetylsalicylate · glycine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2115060A1 (en) *	1970-11-26	1972-07-07	Metabio	Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
ES388158A1 (es) *	1971-02-11	1974-03-16	Liade Sa Lab	Procedimiento de obtencion de sales solubles del acido ace-til salicilico.
JPS4856815A (fr) *	1971-11-13	1973-08-09
JPS55127345A (en) *	1979-03-23	1980-10-02	Kyowa Hakko Kogyo Co Ltd	Preparation of acetylsalicylic acid salt
JPS5610110A (en) *	1979-07-06	1981-02-02	Green Cross Corp:The	Acetyl salicylate salt preparation for injection
JPS56113741A (en) *	1980-02-13	1981-09-07	Mitsui Toatsu Chem Inc	Preparation of crystal of acetylsalicylic acid salt
JPS5721345A (en) *	1980-07-15	1982-02-04	Mitsui Toatsu Chem Inc	Purification of acetylsalicylate salt
CS247688B1 (cs) *	1984-12-22	1987-01-15	Evzen Kasafirek	Způsob výroby soli lysinu s kyselinou acetylsalicylovou
JPS632929A (ja) *	1986-06-20	1988-01-07	Kao Corp	アセチルサリチル酸製剤
EP0499142A3 (en) *	1991-02-09	1993-05-05	Hoechst Aktiengesellschaft	Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
DE4332093C2 (de) *	1993-09-22	1995-07-13	Lohmann Therapie Syst Lts	Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung

2000
- 2000-07-18 DE DE10034802A patent/DE10034802A1/de not_active Withdrawn
2001
- 2001-07-05 PL PL365648A patent/PL204593B1/pl not_active IP Right Cessation
- 2001-07-05 HU HU0302053A patent/HUP0302053A3/hu unknown
- 2001-07-05 ES ES01956511T patent/ES2241849T3/es not_active Expired - Lifetime
- 2001-07-05 DE DE50105985T patent/DE50105985D1/de not_active Expired - Lifetime
- 2001-07-05 RS YUP-20/03A patent/RS50329B/sr unknown
- 2001-07-05 HR HR20030108A patent/HRP20030108B1/xx not_active IP Right Cessation
- 2001-07-05 CZ CZ20030164A patent/CZ300337B6/cs not_active IP Right Cessation
- 2001-07-05 CN CNB018158811A patent/CN1205176C/zh not_active Expired - Fee Related
- 2001-07-05 SK SK67-2003A patent/SK286162B6/sk not_active IP Right Cessation
- 2001-07-05 WO PCT/EP2001/007669 patent/WO2002005782A2/fr not_active Ceased
- 2001-07-05 EP EP01956511A patent/EP1365737B1/fr not_active Expired - Lifetime
- 2001-07-05 AU AU7847101A patent/AU7847101A/xx active Pending
- 2001-07-05 JP JP2002511715A patent/JP2004507463A/ja active Pending
- 2001-07-05 BR BR0112538-9A patent/BR0112538A/pt not_active IP Right Cessation
- 2001-07-05 AT AT01956511T patent/ATE293589T1/de not_active IP Right Cessation
- 2001-07-05 AU AU2001278471A patent/AU2001278471B2/en not_active Ceased
- 2001-07-05 PT PT01956511T patent/PT1365737E/pt unknown
- 2001-07-05 KR KR1020037000713A patent/KR100773658B1/ko not_active Expired - Fee Related
- 2001-07-05 MX MXPA03000510A patent/MXPA03000510A/es active IP Right Grant
- 2001-07-05 DK DK01956511T patent/DK1365737T3/da active
- 2001-07-05 IL IL15387301A patent/IL153873A0/xx unknown
- 2001-07-05 CA CA002416288A patent/CA2416288C/fr not_active Expired - Fee Related
- 2001-07-11 GT GT200100134A patent/GT200100134A/es unknown
- 2001-07-16 UY UY26841A patent/UY26841A1/es not_active Application Discontinuation
- 2001-07-16 US US09/906,497 patent/US6773724B2/en not_active Expired - Lifetime
- 2001-07-16 TW TW090117276A patent/TWI299729B/zh active
- 2001-07-16 MY MYPI20013365A patent/MY134521A/en unknown
- 2001-07-16 AR ARP010103378A patent/AR030305A1/es unknown
- 2001-07-17 SV SV2001000557A patent/SV2002000557A/es unknown
- 2001-07-17 PE PE2001000717A patent/PE20020267A1/es not_active Application Discontinuation
2003
- 2003-01-09 IL IL153873A patent/IL153873A/en not_active IP Right Cessation
- 2003-01-16 NO NO20030222A patent/NO20030222D0/no not_active Application Discontinuation
- 2003-01-17 ZA ZA200300469A patent/ZA200300469B/en unknown
- 2003-01-17 CR CR6888A patent/CR6888A/es unknown
- 2003-01-17 EC EC2003004437A patent/ECSP034437A/es unknown
2004
- 2004-08-09 US US10/915,652 patent/US7449198B2/en not_active Expired - Fee Related
2012
- 2012-03-28 JP JP2012072662A patent/JP2012131824A/ja active Pending

Also Published As

Publication number	Publication date
PT1365737E (pt)	2005-08-31
PL204593B1 (pl)	2010-01-29
PL365648A1 (en)	2005-01-10
HUP0302053A2 (hu)	2003-09-29
SV2002000557A (es)	2002-10-24
CZ300337B6 (cs)	2009-04-22
JP2004507463A (ja)	2004-03-11
US7449198B2 (en)	2008-11-11
KR20030019586A (ko)	2003-03-06
HUP0302053A3 (en)	2010-03-29
SK286162B6 (sk)	2008-04-07
MXPA03000510A (es)	2004-04-20
AR030305A1 (es)	2003-08-20
AU2001278471B2 (en)	2004-07-22
RS50329B (sr)	2009-09-08
GT200100134A (es)	2002-03-22
JP2012131824A (ja)	2012-07-12
ES2241849T3 (es)	2005-11-01
HRP20030108A2 (en)	2005-02-28
MY134521A (en)	2007-12-31
SK672003A3 (en)	2003-06-03
WO2002005782A3 (fr)	2003-10-02
KR100773658B1 (ko)	2007-11-05
WO2002005782A2 (fr)	2002-01-24
CZ2003164A3 (cs)	2003-04-16
PE20020267A1 (es)	2002-06-08
HK1061811A1 (en)	2004-10-08
NO20030222L (no)	2003-01-16
CA2416288A1 (fr)	2003-01-15
CA2416288C (fr)	2009-12-22
CN1468209A (zh)	2004-01-14
CR6888A (es)	2004-10-28
EP1365737B1 (fr)	2005-04-20
DE10034802A1 (de)	2002-01-31
IL153873A (en)	2009-05-04
TWI299729B (en)	2008-08-11
NO20030222D0 (no)	2003-01-16
ZA200300469B (en)	2004-06-21
UY26841A1 (es)	2002-02-28
US20020091108A1 (en)	2002-07-11
BR0112538A (pt)	2003-09-09
YU2003A (sh)	2006-08-17
EP1365737A2 (fr)	2003-12-03
CN1205176C (zh)	2005-06-08
ATE293589T1 (de)	2005-05-15
IL153873A0 (en)	2003-07-31
HRP20030108B1 (en)	2006-12-31
ECSP034437A (es)	2003-03-31
DE50105985D1 (de)	2005-05-25
US6773724B2 (en)	2004-08-10
US20050009791A1 (en)	2005-01-13
AU7847101A (en)	2002-01-30

Publication	Publication Date	Title
NO20030222L (no)	2003-01-16	Stabile salter av O-acetylsalicylsyre med basiske aminosyrer
CY2009011I1 (el)	2010-07-28	Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης
NO20025823L (no)	2002-12-04	Beta-aminosyre nitril derivater
DK2251344T4 (da)	2024-05-13	Formulering af boronsyreforbindelser
ATE353891T1 (de)	2007-03-15	Ditosylatsalze von chinazolinverbindungen
DK1163207T3 (da)	2003-12-01	Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin
DK1449917T3 (da)	2006-11-27	Fremgangsmåde til L-aminosyrefremstilling under anvendelse af Escherichia
AU2001278471A1 (en)	2002-05-02	Stable salts of o-acetylsalicyclic with basic amino acids
FI20002767A7 (fi)	2001-06-22	Jodoniumsuolat latentteina happodonoreina
DK1328499T3 (da)	2010-08-23	Fremgangsmåde til fremstilling af carboxylsyresalte
DE50104794D1 (de)	2005-01-13	Substituierte anthranilsäuren
DK1567482T3 (da)	2010-05-17	Fremgangsmåde til fremstilling af phenylmalonsyre-dinitriler
DK1890994T3 (da)	2012-02-06	Stabilt aktivstofkompleks af salte af O-acetylsalicylsyre med basiske aminosyrer og glycin
DE60217089D1 (de)	2007-02-08	Lipidsenkende biphenylcarbonsäureamide
NO20043404L (no)	2004-08-16	Stabile salter med o-acetylsalisylsyre inneholdende basiske aminosyrer II
DK1377544T3 (da)	2014-08-11	Oprensning af 2-nitro-4-methylsulfonylbenzoesyre
EE200300140A (et)	2003-08-15	PPAR-alfat aktiveerivate omadustega propaanhappe derivaadid
DK1513806T3 (da)	2009-06-15	Sulfonsyresalte af sulfonsyrederivater
DK1648851T4 (da)	2011-12-19	Fremstilling af metalsalte af fedtsyrer med mellemlange kæder
IS7195A (is)	2004-03-23	Ný vatnsfrí kristallaform af gabapentíni
DK1216253T3 (da)	2003-09-15	Fremgangsmåde til fremstilling af methylendiphosphonsyrer og salte deraf
DK1060159T3 (da)	2004-01-05	Syntese af chirale beta-aminosyrer
DK1497290T3 (da)	2008-12-15	Fremgangsmåde til fremstilling af syresalte af gemifloxacin
DK1511741T3 (da)	2013-01-21	Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika
PT1282598E (pt)	2005-03-31	Processo para o fabrico de sais de silfonil-benzoil-guanidinio